Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2008 Jul;22(5):553-62.
doi: 10.1177/0269881108091584.

An Examination of the Effects of the Antioxidant Pycnogenol on Cognitive Performance, Serum Lipid Profile, Endocrinological and Oxidative Stress Biomarkers in an Elderly Population

Affiliations
Controlled Clinical Trial

An Examination of the Effects of the Antioxidant Pycnogenol on Cognitive Performance, Serum Lipid Profile, Endocrinological and Oxidative Stress Biomarkers in an Elderly Population

J Ryan et al. J Psychopharmacol. .

Abstract

The study examines the effects of the antioxidant flavonoid Pycnogenol on a range of cognitive and biochemical measures in healthy elderly individuals. The study used a double-blind, placebo-controlled, matched-pair design, with 101 elderly participants (60-85 years) consuming a daily dose of 150 mg of Pycnogenol for a three-month treatment period. Participants were assessed at baseline, then at 1, 2, and 3 months of the treatment. The control (placebo) and Pycnogenol groups were matched by age, sex, body mass index, micronutrient intake, and intelligence. The cognitive tasks comprised measures of attention, working memory, episodic memory, and psychomotor performance. The biological measures comprised levels of clinical hepatic enzymes, serum lipid profile, human growth hormone, and lipid peroxidation products. Statistically significant interactions were found for memory-based cognitive variables and lipid peroxidation products, with the Pycnogenol group displaying improved working memory and decreased concentrations of F2-isoprostanes relative to the control group.

Similar articles

See all similar articles

Cited by 23 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback